Assessment of safety and tolerability of Herceptin subcutaneous administration in patients with HER2-positive early breast cancer: results of an open-label, randomized, multicenter, phase IIIB study
Talayeva, S., Kaidarova, D., Zhavrid, E., Prokharau, A., Antonenkova, N., Shatkovskaya, O., Manasheva, A., Rutzhanova, Z.Volume:
32
Language:
english
Journal:
The Breast
DOI:
10.1016/s0960-9776(17)30116-9
Date:
March, 2017
File:
PDF, 46 KB
english, 2017